Figures
Abstract
Objective
To expand the current knowledge on the feasibility and safety of laparoscopic total gastrectomy (LTG) for gastric cancer in comparison with open total gastrectomy (OTG).
Background
Additional studies comparing laparoscopic versus open total gastric resection have been published, and it is necessary to update the meta-analysis of this subject.
Methods
Original articles compared LTG and OTG for gastric cancer, which published in English from January 1990 to July 2013 were searched in PubMed, Embase, and Web of Knowledge by two reviewers independently. Operative time, blood loss, harvested lymph nodes, proximal resection margin, analgesic medication, first flatus day, first oral intake, postoperative hospital stay, postoperative complications, hospital mortality, 5-year overall survival (OS) and disease-free survival (DFS) were compared using STATA version 10.1.
Results
17 studies were selected in this analysis, which included a total of 2313 patients (955 in LTG and 1358 in OTG). LTG showed longer operative time, less blood loss, fewer analgesic uses, earlier passage of flatus, quicker resumption of oral intake, earlier hospital discharge, and reduced postoperative morbidity. The number of harvested lymph nodes, proximal resection margin, hospital mortality, 5-year OS and DFS were similar.
Conclusion
LTG had the benefits of less blood loss, less postoperative pain, quicker bowel function recovery, shorter hospital stay and lower postoperative morbidity, at the price of longer operative time. There were no statistical differences in lymph node dissection, resection margin, hospital mortality, and long-term outcomes, which indicated the similar oncological safety with OTG. A positive trend was indicated towards LTG. So LTG can be performed as an alternative to OTG by the experienced surgeons in high-volume centers. Whereas, due to the relative small sample size of long-term outcomes and lack of randomized control trials, more studies are required.
Citation: Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z (2014) Laparoscopic versus Open Total Gastrectomy for Gastric Cancer: An Updated Meta-Analysis. PLoS ONE 9(2): e88753. https://doi.org/10.1371/journal.pone.0088753
Editor: Helge Bruns, University Hospital Heidelberg, Germany
Received: August 20, 2013; Accepted: January 12, 2014; Published: February 18, 2014
Copyright: © 2014 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Natural Science Foundation of China (No. 81072031, 81272712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Since the first laparoscopic gastrectomy for gastric caner was performed by Japanese surgeons in 1991 [1], laparoscopic distal gastrectomy (LDG) for early gastric cancer has gained widely acceptance for its minimal invasion compared with open distal gastrectomy (ODG). Many studies have demonstrated the benefits of LDG over open surgery, such as less blood loss, shorter hospital stay, accelerated recovery, extended lymphadenectomy and reduced postoperative complications [2]–[6]. Moreover, the indications for LDG even extended from early gastric cancer to advanced gastric cancer [7]–[10]. However, limited surgeons chose laparoscopic total gastrectomy (LTG) instead of open total gastrectomy (OTG) for proximal or middle-third gastric cancer due to the technical difficulties in sufficient lymph node dissection, vascular procedures along the greater curvature of the proximal stomach and the performance of esophagojejunostomy. With the development of the laparoscopic instruments and the increasing experiences in complex gastric procedures, the use of LTG is increasing annually. Several studies have reported the use of LTG as the treatment of gastric cancer and indicate its potential superiority [11], [12]. Recently, a meta-analysis published by Haverkamp et al. also demonstrated the better short-term outcomes of LTG compared with OTG [13]. Nevertheless, only eight studies were involved in this meta-analysis and most of them focused on the early gastric cancer with a small sample size, lacking long-term outcomes. Thus, the feasibility and safety of LTG are still needed further validation. Because seven additional studies which contain more cases of advanced gastric cancer and more survival data, have now been published, we thought to perform an updated meta-analysis to broaden the current knowledge on the feasibility and safety of LTG for gastric cancer.
Materials and Methods
Literature search
Literatures that published in English from January 1990 to July 2013 were searched in the following database: PubMed, Embase, and Web of Knowledge. The keywords “laparoscopic”, “total gastrectomy”, “gastric cancer”, “randomized controlled trial”, “prospective study”, and “comparative study” were used. Then, all titles, abstracts, or related citations were scanned and reviewed.
Inclusion and exclusion criteria
Inclusion criteria were described as follow: (1) studies that compared LTG with OTG for gastric cancer; (2) LTG that was performed with either laparoscopy-assisted or total laparoscopic approach; (3) any type of comparative study; (4) studies with any size.
Exclusion criteria were used as follows: (1) studies including other types of gastric resection, unless the data were presented separately; (2) studies in which <3 interested indexes were reported, or the indexes were difficult to calculate from the results; (3) overlapping data.
Quality assessment of the studies
Newcastle–Ottawa Quality Assessment Scale for cohort studies (NOS) (Table 1) [14], which is recommended in the Cochrane Handbook version 5.1.0, was used to evaluate the quality of the nonrandomized studies by two independent reviewers. Eight elements in this scale are used to assess patient population and selection, study comparability, follow-up, and outcome of interest. High-quality elements are awarded by adding a star, and then the stars are added up to compare the study quality. Each study was graded as either low quality (0–5) or high quality (6–9). The results were presented in Table 2, and the low-quality studies were excluded. Any discrepancies were resolved by a consensus reviewer.
Methods of review
The data was extracted and critically appraised independently by two authors. We extracted operative time, blood loss, number of harvested lymph nodes, and proximal resection margin to assess the effectiveness of the procedures. The analgesic medication, first flatus day, first oral intake and hospital stay were used to compare the postoperative recovery of the procedures. The postoperative complications including wound infection, anastomotic leakage, anastomotic stenosis, postoperative ileus, pneumonia, pancreatitis, intra-abdominal abscess and adhesive bowel obstruction were compared. The hospital mortality, 5-year overall survival (OS) and disease free survival (DFS) were used to estimate the postoperative safety of LTG.
Statistical analysis
We used weighted mean differences (WMD) with 95% confidence intervals (CI) to analyze continuous variables presented in the same scale (i.e., operative time, blood loss, postoperative hospital stay). When a study reported a range instead of standard deviation (SD), a quarter of the range amplitude was equivalent to the estimated SD [15]. Dichotomous data was calculated by relative risks (RR). OS and DFS were evaluated by pooled hazard ratios (HR) and their 95% confidence intervals (CI). HRs and their 95% CIs for OS and DFS were obtained from the original study. If the study did not directly report the HR and 95% CI, we used the published methods to calculate them [16], [17]. Plot Digitizer version 2.6.3 was used to read Kaplan-Meier curves of the included studies (free software downloaded from http://plot-digitizer.softpedia.com/). HR calculation spreadsheet was used to calculate the HR and 95% CI (freely downloaded from http://www.trialsjournal.com/content/supplementary/1745-6215-8-16-s1.xls). Random effects models were used owing to the high heterogeneity of the studies, otherwise, fixed-effects models were used [18], [19]. We used the Cochran's Q – test to assess heterogeneity, and P<0.1 was considered significant. Galbraith plot was used to identify the major contributors to heterogeneity [20]. And in order to explore the heterogeneity among the outcome variables better, we examined study quality (<8 and ≥8), year of publication (before and after 2012), country of patients (eastern and western), sample size (<50 and ≥50), stage of gastric cancer (early, advanced and both) and lymph nodes dissection (D1, D2 and both) in meta-regression model. Subgroup analyses according to the meta-regression results and study characteristics were performed to explore the possible explanations of the heterogeneity and to assess the potential effect of these factors on outcomes. Funnel plots and Egger's linear regression test were used to assess the publication bias [21]. All statistical calculations were completed by using STATA (version 10.1, StataCorp LP, College Station, TX). A two-trailed value of P<0.05 was considered significant.
Results
Search results
The electronic search strategy identified 195 articles that mentioned laparoscopic gastrectomy and open gastrectomy for gastric cancer. After screening the titles, abstracts, full texts, or a combination of these, we selected articles based on the inclusion and exclusion criteria (Fig 1). Finally, 18 articles that compared LTG with OTG were included [22]–[39]. Then the NOS was used to assess the quality of each study and one study was excluded for its low scores [32]. Finally, 17 studies were selected for this analysis (Table 3). In Haverkamp et al.'s study [13], two articles were regarded as contributor to high risk of bias [23], [33] and were excluded at last. But in our assessment, these two studies were graded as high quality and were included in our meta-analysis.
Characteristics of the studies
All the articles were published between 2005 and 2013. A total of 2313 patients were involved in the meta-analysis, which contained 955 people undergoing LTG and 1358 people receiving OTG. Fourteen studies were published by Asian investigators, and only three were reported by the western scholars. This result can be explained by the high incidence of gastric cancer in eastern countries. And the conclusions might bias to the Asians. As shown in Table 4, five articles reported the treatment for patients with early gastric cancer (EGC) [23], [24], [27], [30], [31], and three studies focused on the patients with advanced gastric cancer (AGC) [29], [38], [39]. The rest of the nine articles described both populations [22], [25], [26], [28], [33]–[37]. The mean age of the studies ranged from 50 to 75 years, and distributed similarly in the two procedures. The frequency of the gender was also found distributing equally in the two groups. A similar mean BMI between 22 and 24 kg/m2 was observed in most studies expect one [31], however, when we pooled the data together, the patients in LTG group was found having a lower mean BMI (WMD, −0.32; 95% CI, −0.62, −0,01; P = 0.041). We also compared the tumor size. Apart from two studies that reported the statistical difference [24], [28], the rest six showed no significant difference [22], [26], [29]–[31], [38]. What's more, all studies described the similar distribution of pTNM stages and ASA scores except two [28], [31].
D1 lymph node dissection of total gastrectomy, which requires the retrieval of lymph nodes along the left gastric artery and the common hepatic artery, around the celiac artery, was performed in three articles [22]–[24]. Modified D2 lymph node dissection of total gastrectomy (without pancreatectomy and splenectomy), which refers to the removal of additional lymph nodes around the splenic artery and hilus of the spleen, and those located in the hepatoduodenal ligament, was achieved in nine articles [26], [27], [29]–[31], [36]–[39]. In the rest five studies, both D1 and D2 dissection were used [25], [28], [33]–[35]. All the studies reported the performances of Roux-en-Y reconstruction and esophagojejunal anastomosis.
Operative findings
There was a longer duration of operative time in the LTG group than that in the OTG group (WMD, 47.00; 95% CI, 31.67, 62.33; P<0.001) (Fig 2A). However, significant heterogeneity (I2 = 93.1%, P<0.001) and the publication bias (t = 2.93; P = 0.010) were observed. Therefore, we used the Galbraith plot to find the source of heterogeneity [24], [25], [28], [29], [31], [35], [37]–[39], and excluded them all. Then, we meta-analyzed this subject again and still found the same outcome (WMD, 22.86; 95% CI, 17.18, 28.53; P<0.001) with low heterogeneity (I2<0.1%, P = 0.890) and no publication bias (t = 0.31; P = 0.764). Blood loss during the operation was decreased under the laparoscopic procedure (WMD, −179.60; 95% CI, −251.80, −107.89; P<0.001) (Fig 2B). No statistical difference was found between the two groups in the number of harvested lymph nodes (WMD, 2.33; 95% CI, −0.04, 4.71; P = 0.054) (Fig 2C). We also analyzed the retrieval of lymph nodes under the modified D2 lymphadenectomy between LTG and OTG, and no difference was discovered (WMD, 0.70; 95% CI, −0.80, 2.20; P = 0.361) (Fig 2D). Moreover, the effect of No. 10 lymph nodes dissection under D2 lymphadenectomy on the number of harvested lymph nodes was assessed, and no significant difference between the two groups was found (with No. 10 lymph nodes dissection: WMD, −0.40; 95% CI, −2.55, 1.75; P = 0.715; without No. 10 lymph nodes dissection: WMD, 1.76; 95% CI, −0.35, 3.87; P = 0.102). The length of the proximal resection margin was similar for either group (WMD, 0.06; 95% CI, −0.26, 0.39; P = 0.706) (Fig 2E).
Postoperative clinical course
The postoperative pain patients suffered was evaluated by counting the times of the analgesics use. Patients receiving the laparoscopic procedure used fewer analgesics (WMD, −2.46; 95% CI, −2.71, −2.22; P<0.001) (Fig 3A). The outcomes also favored LTG in first flatus day (WMD, −0.80; 95% CI, −1.11, −0.50; P<0.001) (Fig 3B) and first oral intake (WMD, −1.11; 95% CI, −1.57, −0.64; P<0.001) (Fig 3C), which indicated a quicker recovery of the bowl function. Moreover, postoperative hospital day was 3.37 days shorter for LTG patients (WMD, −3.37; 95% CI, −4.58, −2.16; P<0.001) (Fig 3D).
Morbidity, hospital mortality and long-term survival
In the subcategory analysis of postoperative complications, patients in LTG group showed less wound infection (RR, 0.35; 95% CI, 0.20, 0.61; P<0.001). No statistical differences were found in anastomotic leakage, anastomotic stenosis, postoperative ileus, pneumonia, pancreatitis, intra-abdominal abscess and adhesive bowel obstructions between the two groups (Table 5). The overall postoperative morbidity was lower for LTG than OTG (RR, 0.78; 95% CI, 0.66, 0.94; P = 0.007) (Fig 4A), and the reduction of postoperative morbidity was also observed in the patients under LTG with D2 dissection when compared with patients under OTG with D2 dissection (RR, 0.70; 95% CI, 0.52, 0.94; P = 0.017) (Fig 4B). There were no significant differences in hospital mortality (RR, 0.94; 95% CI, 0.31, 2.82; P = 0.910; D2 dissection subgroup: RR, 0.57; 95% CI, 0.11, 3.09; P = 0.513). Six articles reported the 5-year OS of both procedures. One article directly provided the HR and the 95% CI for OS [31]. We calculated the HR and their 95% CIs from three articles [24], [34], [39] by using the published methodology. And we could not extract the HR and 95% CIs from the rest two studies due to the lack of information [33], [39]. Then, we pooled the data together, and found a favoring trend to LTG with no statistical difference (HR, 0.81; 95% CI, 0.51, 1.28; P = 0.360) (Fig 4C). The 5-year DFS was extracted from three studies and analyzed [24], [31], [34]. The DFS in LTG was similar with that in OTG (HR, 0.62; 95% CI, 0.30, 1.27; P = 0.191) (Fig 4D).
Meta-regression
According to Cochrane Handbook, when a meta-analysis contains fewer than ten studies, meta-regression should generally not be considered. Therefore, we just examined the outcome variables with high heterogeneity, which included more than ten studies, in a meta-regression model. The analyses indicated that study quality, country of patients, sample size, and lymph nodes dissection were significant sources of heterogeneity (Table 6).
Subgroup-analysis
As shown in Table 7, subgroup-analyses were performed by the sources of heterogeneity (study quality, country of patients and sample size), and the study characteristics we cared about (stage of gastric cancer). Because the extent of lymph node dissection is an important factor that may affect our judgment about the safety and feasibility of laparoscopic surgery, we had described the outcomes of LTG with D2 dissection in the main results above. In operative time, no decreasing trend was found in the studies with more than 50 LTG cases, and even more time was used (<50 cases: 42.97 min; ≥50 cases: 52.34 min). In blood loss, we also did not observe the statistical differences between LTG and OTG in the studies with larger sample size (≥50 cases: WMD, −82.46; 95% CI, −166.23, 1.31; P = 0.054). In the number of harvested lymph nodes, more lymph nodes were retrieved under OTG in the high score studies (≥8 scores: WMD, 2.56; 95% CI, 0.52, 4.59; P = 0.014). The fewer postoperative complications were only found in studies of AGC and articles with <8 scores (AGC: RR, 0.50; 95% CI, 0.35, 0.73; P<0.001; <8 scores: RR, 0.78; 95% CI, 0.61, 0.99; P. = 0.043). The rest outcomes remained unchanged in the subgroups.
Sensitivity and Publication Bias
We used the funnel plots and Egger's linear regression test to detect publication bias for each result. When the number of studies was small, there was a limitation in this test. So the funnel plots of proximal resection margin, analgesic medication, hospital mortality, 5-year OS and DFS, were not showed. Eventually, seven funnel plots were constructed for the outcomes we most cared about. The symmetry of most outcomes on the whole was observed. All the outcomes showed no significant publication bias (P>0.05) except operative time (t = 2.93; P = 0.010) (Fig 5). Galbraith plot was used to find which articles were the contributors to heterogeneity. Then we excluded these articles and analyzed the pooling data of the rest. The same conclusions were found.
A, operative time; B, blood loss; C, harvested lymph nodes; D, first flatus day; E, first oral intake; F, hospital stay; G, postoperative complications.
Discussion
According to “Gastric Cancer Treatment Guidelines in Japan, 2010”, total gastrectomy is used in radical resection of proximal and middle third gastric cancer. Laparoscopic surgery is recommended as a treatment for early gastric cancer and clinical research. Patient's preference and surgeon's suggestion may affect the choice of operation type. And cosmetic result, cost, recovery and pain are the major factors the patients care about [5], [40]–[43]. Recently, a meta-analysis has shown the superiority of LTG to OTG [13], however, the oncological outcome and long-term outcomes are still needed to evaluate. With the development of laparoscopic technique, the number of LTG use is increasing, and seven additional articles that compared the LTG with OTG have been published. Therefore, we performed this updated meta-analysis to estimate the value of LTG.
The randomized controlled trials (RCTs) are our first choice for the high quality of the outcomes. But no RCTs focusing on this subject were found. Eighteen non-randomized comparative cohort studies were selected. In order to get convincible results from articles, NOS was used to assess the quality of the studies and one low-quality study was excluded. Then, we compared the clinical characteristics between the two groups and no statistical differences were found in age, sex, ASA and pTNM stages except BMI which was lower in LTG groups. This finding indicated that selection bias might exist among the studies. Surgeons might prefer to perform LTG on thinner people and our conclusion might bias to laparoscopic procedures. Considering that more than half of the articles reported the gastrectomy with D2 dissection, which was preferred by Asian surgeons, the fact that most studies we collected were from eastern countries was reasonable. Compared with patients in western countries, Asian patients are younger, slimmer and healthier [44]. These factors were associated with better postoperative outcomes after open gastrectomy [45]–[47]. So there might be a bias to Asian people in our analysis. Thus, we assessed the outcomes of the western patients in the subgroup, and the similar results were found expect the lower postoperative morbidity. Because only three studies were involved, more studies were needed. Publication bias for each variable was detected by using funnel plots and Egger's linear regression test, and no significant publication bias of each outcome was found except operative time. In general, because the quality of all the studies was assured by NOS and most of the clinical characteristics were matched, the two groups were comparable.
Due to the lack of tactile sensation, narrow operating field, complicated vascular structure in the splenic hilum, and the advanced techniques for systemic lymph node dissection, LTG was regarded as a time-consuming procedure. Haverkamp et al. also reported a longer duration of operative time in LTG groups [13]. Early learning curve, the familiarity with the laparoscopic system and the cooperation of the whole therapeutic team were thought as the factors that influence the operative time [48]. According to the studies of learning curve in LDG, 40–60 cases are needed [48]–[50]. Thus, we used 50 LTG cases as a cut point and performed the subgroup analysis. However, no reduction in LTG operative time was observed and even more time was used. Our result suggested that learning curve was not the main cause of the longer time, which was consistent with the conclusion that even with experienced gastrointestinal and laparoscopic surgeons, laparoscopic gastrectomy is still a time-consuming procedure [51]. Thus, the complexity of LTG and the shortage of the laparoscopic equipments might be the main reason. With the technological improvement and the development of the instruments, the reduction of the operating time has been observed in LDG [51], [52]. It is believed that the time for LTG will decrease in the future.
In spite of the longer operative time, a significant decrease of blood loss for laparoscopic approach was found compared with open procedure, which indicated fewer transfusions during the operation. The enlarged laparoscopic surgical field with the advantage of better vessel exposing and identifying contributed to this outcome, which is also attributed to the use of special instruments, such as the ultrasonic scalpel and ligatures [53]. The recovery of the patients was affected by both the amount of blood loss and the requirement of transfusion [54], [55]. The less blood loss can reduce the risk of acute or late adverse effects such as acute lung injury, volume overload, hypothermia, etc. However, in the subgroup analysis, this benefit was not observed in the studies with higher scores, although there was a tendency favoring LTG. Further validations are still required.
The length of resection margin can influence the rate of tumor-free margins. Thus, whether LTG can resect the similar length as OTG is very important for the oncological safety. Because the resection of proximal stomach is more difficult than the duodenal resection, most of the involved articles just provided the length of proximal resection margin. No statistical difference of this subject was found, which indicated the similar ability of proximal resection between LTG and OTG. This finding can also explain the similar positive rate of resection margin reported by three studies [22], [26], [29].
The results were significantly favoring for LTG in the use of analgesics, first flatus day, first oral intake and the length of hospital stay. In this analysis, the times of the analgesics use were extracted to evaluate the postoperative pain, because pain-feeling is hard to measure for its subjectivity. Less pain during recovery is most likely caused by the minimal invasiveness of LTG and it suggests earlier recovery and better quality of life. Earlier passage of flatus represents a quicker recovery of bowel function, which has a direct impact on earlier resumption of oral intake and earlier discharge from hospital. Minimal gastrointestinal interference and the use of small incision can explain all the advantages above, and can also decrease surgical stress, therefore reduce the generalized inflammatory reaction, leading to a reduction of postoperative morbidity.
The extent of lymph node dissection is a critical factor for oncological adequacy. D1 dissection is now accepted as a standard treatment for selected patients with early gastric cancer. Debate about whether D2 dissection for curable advanced gastric cancer is superior to D1 dissection still exists. The more complexity and invasiveness of D2 dissection are thought to increase the postoperative complications and mortality. Whereas, D2 dissection is possible to remove more positive nodes than D1 dissection, which is necessary to minimize stage migration[56]. The western scholars preferred the D1 dissection because some European reports have shown that D2 dissection had no survival advantages but with a higher operative morbidity and mortality rates [57]–[59]. On the other hand, the high incidence of gastric caner makes Asian surgeons more familiar with gastrectomy, which results in better understanding of the indications of D2 dissection and surgical technique. Therefore, D2 dissection is recommended by many eastern surgeons for the improved long-term survival [60]–[62]. According to “Gastric Cancer Treatment Guidelines in Japan, 2010”, standard radical gastrectomy was even defined as: more than two-thirds of proximal, distal, or total gastrectomy associated with D2 dissection. And more recent reports have demonstrated that European surgeons can be trained to perform D2 dissection for selected western patients with better postoperative outcomes and a survival benefit [63]–[66]. Thus, D2 dissection is felt to be a more appropriate treatment for patients with advanced disease at present. Recently, LTG with D2 dissection (LTGD2) has been reported to be feasible in the hands of experienced surgeons [67]. Nevertheless, the difficulty of performing LTGD2 may affect the benefits of laparoscopic surgery. Considering our analysis including nine studies of D2 dissection, it is necessary to analyze the number of harvested lymph nodes, postoperative morbidity and hospital mortality after the gastrectomy with D2 dissection in the subgroup.
The number of harvested lymph nodes is used to evaluate the oncological adequacy. According to UICC (Union for International Cancer Control), the removal of at least fifteen lymph nodes is beneficial for pathological examination. The mean number of lymph nodes retrieved by LTG was adequate in all studies. In Haverkamp et al.'s analysis, more lymph nodes were harvested by OTG than by LTG, though no significant difference was found. In our analysis, we discovered the same results, which indicated the similar ability of lymph nodes clearance between the two procedures. Considering the difficulty of clearing the lymph nodes around the splenic artery and hilus of the spleen under LTGD2, the measurement of adequate lymphadenectomy by LTGD2 is necessary. The similar clearance of lymph nodes was also observed. In D2 dissection of total gastrectomy, splenectomy is performed to resect lymph nodes around splenic artery (No. 11) and hlium (No. 10). But splenectomy was reported associated with higher postoperative morbidity and mortality without survival benefits [68]–[70]. According to the recent Guidelines from the National Comprehensive Cancer Network (NCCN), splenectomy is recommended only when spleen or hilum is involved, and modified D2 dissection (without pancreatectomy and splenectomy) is suggested performed by experienced surgeons in high-volume centers for patients with localized resectable cancer. Nine studies in our meta-analysis reported the performance of LTG with modified D2 dissection, and eight of them showed the number of harvested lymph nodes. All the studies pronounced the dissection of No. 11 lymph nodes and four studies did not mention the retrieval of No. 10 lymph nodes. Two studies can be explained by the low incidence of hilar lymph nodes metastasis in early gastric cancer [27], [31]. The other two did not show us the reason why they performed the LTGD2 for advanced gastric cancer without the clearance of No. 10 lymph nodes [29], [39]. The difficulty of splenic hilar lymphadenectomy by using spleen-preserving LTG due to the complicated anatomic relationship between lymph nodes and vessels around splenic hilum may explain it. Therefore, we also assessed the effect of No. 10 lymph nodes dissection on the number of harvested lymph nodes. And no statistical difference was found regardless of the removal of No. 10 lymph nodes dissection between LTG and OTG. All above demonstrated that LTG had a similar ability of lymph nodes clearance compared with OTG, but there is one important thing we should notice. In the studies with higher scores, OTG was believed to retrieve more lymph nodes. Combing with the result that a favoring trend towards OTG was found in the other subgroups, further validation of this subject are still needed.
The postoperative morbidity is an important outcome to assess the safety of the operation type. In the subcategory analysis, reduced wound infection in LTG group was found due to the scattered trocar incisions and contractible sample-extraction incision. The same technique of digestive reconstruction in both procedures could explain the similar incidence of anastomotic leakage and stenosis. The minimal invasiveness of laparoscopic surgery could reduce the intervention to microenvironment of abdominal cavity and injury of intestinal serous membrane, which was thought being able to decrease the occurrence of postoperative ileus, pneumonia, pancreatitis, intra-abdominal abscess and adhesive bowel obstructions. In our analysis, we did not observe any statistical difference in these aspects, but a favorable trend in LTG was found. The relative small sample size in the subcategory might be the reason. When we pooled the data together, the patients undergoing LTG were associated with a significant reduction of total postoperative complications. And the same result was also found in the subgroup of D2 dissection. But in the other subgroups, only the studies of AGC or articles with <8 scores showed the fewer postoperative complications in LTG groups. Considering that low heterogeneity was found in the overall result and the rest subgroups showed a tendency towards LTG, this result can be explained by a relative small sample size in subgroups, which did not have enough volume to show the statistical difference. Therefore, the lower postoperative morbidity in LTG group should be reliable.
Our analysis revealed that there was no significant difference in hospital mortality between the two groups. And in the subgroup of D2 dissection, the same conclusion was found. These suggested the equivalent short-term prognosis between LTG and OTG. Long-term outcome is the most important factor used for evaluating the oncological safety of one surgery. The majority of recurrences occurs during the first two years after surgery [71], so we used two years as the qualification for NOS to assess the adequate follow-up period of each study. We extracted the 5-year OS and DFS from all available articles. Although the results favored LTG, there were no statistical differences indeed. Combining with the similar lymph nodes clearance and proximal resection, we could say LTG has the similar oncological safety and adequacy with OTG in some extent. However, the relative small sample size in long-term outcomes made our conclusion not convincible enough. More studies focusing on this subject are still needed.
In conclusion, with the less blood loss, quicker postoperative recovery, reduced postoperative morbidity, and similar oncological safety, LTG is a feasible and safe surgery for gastric cancer. LTG can be performed as an alternative to OTG for selected patients by experienced surgeons in high-volume centers. However, well-designed RCTs in multicenter and the comparative studies of long-term outcomes are still needed for further validation.
Author Contributions
Conceived and designed the experiments: ZX BW. Performed the experiments: WW X. Zhang. Analyzed the data: WW CS. Contributed reagents/materials/analysis tools: X. Zhi. Wrote the paper: WW.
References
- 1. Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4: 146–148.
- 2. Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, et al. (2002) A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery 131: S306–311.
- 3. Hayashi H, Ochiai T, Shimada H, Gunji Y (2005) Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer. Surg Endosc 19: 1172–1176.
- 4. Lee JH, Han HS (2005) A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc 19: 168–173.
- 5. Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, et al. (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248: 721–727.
- 6. Vinuela EF, Gonen M, Brennan MF, Coit DG, Strong VE (2012) Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 255: 446–456.
- 7. Song KY, Kim SN, Park CH (2008) Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer: technical and oncologic aspects. Surg Endosc 22: 655–659.
- 8. Hur H, Jeon HM, Kim W (2008) Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy for T2b advanced gastric cancers: three years' experience. J Surg Oncol 98: 515–519.
- 9. Kawamura H, Homma S, Yokota R, Yokota K, Watarai H, et al. (2008) Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy-assisted distal gastrectomy. World J Surg 32: 2366–2370.
- 10. Hamabe A, Omori T, Tanaka K, Nishida T (2012) Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc 26: 1702–1709.
- 11. Takiguchi S, Sekimoto M, Fujiwara Y, Miyata H, Yasuda T, et al. (2005) A simple technique for performing laparoscopic purse-string suturing during circular stapling anastomosis. Surg Today 35: 896–899.
- 12. Lee SE, Ryu KW, Nam BH, Lee JH, Kim YW, et al. (2009) Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol 100: 392–395.
- 13. Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, et al. (2013) Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc 27: 1509–1520.
- 14.
GA W, L B, D OC, B S, D H, et al.. (2003) An Evaluation of the Newcastle Ottawa Scale: An Assessment Tool for Evaluating the Quality of Non-Randomized Studies. In XI Cochrane Colloquium VolO-63p26 Barcelona: XI International Cochrane Colloquium Book of Abstracts.
- 15. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5: 13.
- 16. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815–2834.
- 17. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
- 18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
- 19. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748.
- 20. Galbraith RF (1988) Graphical display of estimates having differing standard errors. Technometrics 30: 271–81.
- 21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.
- 22. Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, et al. (2005) Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc 19: 933–938.
- 23. Usui S, Yoshida T, Ito K, Hiranuma S, Kudo SE, et al. (2005) Laparoscopy-assisted total gastrectomy for early gastric cancer: comparison with conventional open total gastrectomy. Surg Laparosc Endosc Percutan Tech 15: 309–314.
- 24. Mochiki E, Toyomasu Y, Ogata K, Andoh H, Ohno T, et al. (2008) Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc 22: 1997–2002.
- 25. Kim SG, Lee YJ, Ha WS, Jung EJ, Ju YT, et al. (2008) LATG with extracorporeal esophagojejunostomy: is this minimal invasive surgery for gastric cancer? J Laparoendosc Adv Surg Tech A 18: 572–578.
- 26. Topal B, Leys E, Ectors N, Aerts R, Penninckx F (2008) Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc 22: 980–984.
- 27. Kawamura H, Yokota R, Homma S, Kondo Y (2009) Comparison of invasiveness between laparoscopy-assisted total gastrectomy and open total gastrectomy. World J Surg 33: 2389–2395.
- 28. Sakuramoto S, Kikuchi S, Futawatari N, Katada N, Moriya H, et al. (2009) Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy. Surg Endosc 23: 2416–2423.
- 29. Du J, Zheng J, Li Y, Li J, Ji G, et al. (2010) Laparoscopy-assisted total gastrectomy with extended lymph node resection for advanced gastric cancer–reports of 82 cases. Hepatogastroenterology 57: 1589–1594.
- 30. Kim MG, Kim BS, Kim TH, Kim KC, Yook JH (2011) The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc 80: 245–250.
- 31. Eom BW, Kim YW, Lee SE, Ryu KW, Lee JH, et al. (2012) Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc 26: 3273–3281.
- 32. Arrington AK, Nelson R, Chen SL, Ellenhorn JD, Garcia-Aguilar J, et al. (2012) The evolution of surgical technique for total gastrectomy over a 12-year period: a single institution's experience. Am Surg 78: 1054–1058.
- 33. Kunisaki C, Makino H, Kosaka T, Oshima T, Fujii S, et al. (2012) Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study. Surg Endosc 26: 804–810.
- 34. Siani LM, Ferranti F, De Carlo A, Quintiliani A (2012) Completely laparoscopic versus open total gastrectomy in stage I-III/C gastric cancer: safety, efficacy and five-year oncologic outcome. Minerva Chir 67: 319–326.
- 35. Jeong O, Jung MR, Kim GY, Kim HS, Ryu SY, et al. (2012) Comparison of short-term surgical outcomes between laparoscopic and open total gastrectomy for gastric carcinoma: case-control study using propensity score matching method. J Am Coll Surg 216(2): 184–91.
- 36.
Guan G, Jiang W, Chen Z, Liu X, Lu H, et al.. (2012) Early results of a modified splenic hilar lymphadenectomy in laparoscopy-assisted total gastrectomy for gastric cancer with stage cT1-2: a case-control study. Surg Endosc.
- 37.
Lee MS, Lee JH, Park DJ, Lee HJ, Kim HH, et al.. (2013) Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc.
- 38. Kim HS, Kim BS, Lee IS, Lee S, Yook JH (2013) Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A 23: 323–331.
- 39. Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, et al. (2013) Laparoscopy-assisted vs. open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study. J Gastrointest Surg 17: 1202–1208.
- 40. Mochiki E, Kamiyama Y, Aihara R, Nakabayashi T, Asao T, et al. (2005) Laparoscopic assisted distal gastrectomy for early gastric cancer: Five years' experience. Surgery 137: 317–322.
- 41. Memon MA, Khan S, Yunus RM, Barr R, Memon B (2008) Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc 22: 1781–1789.
- 42. Ryu KW, Kim YW, Lee JH, Nam BH, Kook MC, et al. (2008) Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Ann Surg Oncol 15: 1625–1631.
- 43. Lee SE, Kim YW, Lee JH, Ryu KW, Cho SJ, et al. (2009) Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol 16: 2231–2236.
- 44. Griffin SM (2005) Gastric cancer in the East: same disease, different patient. Br J Surg 92: 1055–1056.
- 45. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, et al. (2005) Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 92: 1103–1109.
- 46. Lee JH, Paik YH, Lee JS, Ryu KW, Kim CG, et al. (2007) Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol 14: 1288–1294.
- 47. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, et al. (2009) Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg 144: 351–358 discussion 358.
- 48. Kim MC, Jung GJ, Kim HH (2005) Learning curve of laparoscopy-assisted distal gastrectomy with systemic lymphadenectomy for early gastric cancer. World J Gastroenterol 11: 7508–7511.
- 49. Jin SH, Kim DY, Kim H, Jeong IH, Kim MW, et al. (2007) Multidimensional learning curve in laparoscopy-assisted gastrectomy for early gastric cancer. Surg Endosc 21: 28–33.
- 50. Kunisaki C, Makino H, Yamamoto N, Sato T, Oshima T, et al. (2008) Learning curve for laparoscopy-assisted distal gastrectomy with regional lymph node dissection for early gastric cancer. Surg Laparosc Endosc Percutan Tech 18: 236–241.
- 51. Fujiwara M, Kodera Y, Miura S, Kanyama Y, Yokoyama H, et al. (2005) Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a phase II study following the learning curve. J Surg Oncol 91: 26–32.
- 52. Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, et al. (2000) Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg 135: 806–810.
- 53. Ohtani H, Tamamori Y, Noguchi K, Azuma T, Fujimoto S, et al. (2010) A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer. J Gastrointest Surg 14: 958–964.
- 54. Spence RK, Carson JA, Poses R, McCoy S, Pello M, et al. (1990) Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 159(3): 320–4.
- 55. Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, et al. (2010) Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 252(1): 11–7.
- 56. de Manzoni G, Verlato G, Roviello F, Morgagni P, Di Leo A, et al. (2002) The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 87: 171–174.
- 57. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, et al. (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908–914.
- 58. Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, et al. (2004) Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 30: 643–649.
- 59. Danielson H, Kokkola A, Kiviluoto T, Siren J, Louhimo J, et al. (2007) Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg 96: 35–40.
- 60. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T (1989) Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210: 596–602.
- 61. Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF (1989) Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 64: 2053–2062.
- 62. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79: 1522–1530.
- 63. Degiuli M, Sasako M, Ponti A (2010) Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg 97: 643–649.
- 64. Sierra A, Regueira FM, Hernandez-Lizoain JL, Pardo F, Martinez-Gonzalez MA, et al. (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10: 219–226.
- 65. Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, et al. (2007) Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg 245: 426–434.
- 66. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11: 439–449.
- 67. Shinohara T, Kanaya S, Taniguchi K, Fujita T, Yanaga K, et al. (2009) Laparoscopic total gastrectomy with D2 lymph node dissection for gastric cancer. Arch Surg 144: 1138–1142.
- 68. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, et al. (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 131: 401–407.
- 69. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, et al. (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22: 2069–2077.
- 70. Yu W, Choi GS, Chung HY (2006) Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 93: 559–563.
- 71. McCulloch P (2006) The role of surgery in patients with advanced gastric cancer. Best Pract Res Clin Gastroenterol 20: 767–787.